Could a simple pill make endoscopy smoother?
NCT ID NCT07271303
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a capsule form of hyoscine butylbromide (Buscopan) can reduce stomach and intestinal movements during painless gastrointestinal endoscopy, potentially improving the doctor's view and procedure accuracy. The trial will involve 74 adults scheduled for upper endoscopy, comparing the drug to a placebo. The main goal is to see if the pill reduces peristalsis (natural gut movements) without the need for injections.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
hyoscine butylbromide (Buscopan) capsules
What this could lead to
If it works, this could offer a pill that reduces stomach movement during endoscopy, making the procedure easier and less painful for patients.
What could go wrong
This is a small, early-stage trial with only 74 participants, so results may not apply to everyone. The drug may cause side effects like dry mouth or blurred vision.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAINLESS GASTROINTESTINAL ENDOSCOPY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.